Dear Sir/Madam, Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, it is hereby informed that the Board of Directors at their ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Prism Medico and Pharmacy Ltd has submitted a disclosure to BSE under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. The filing relates to a meeting of the Board of Directors of the company. The full text of the announcement is truncated, so the specific agenda items, decisions, or outcomes from the board meeting are not visible in the provided content. Shareholders will need to refer to the complete filing on the BSE website for detailed information on what was discussed or approved.
Without visibility into the actual board decisions, no clear short-term impact on the stock or shareholders can be assessed. Investors should check the full announcement for any material decisions such as fundraising, acquisitions, results, or changes in directors.